Related Experiment Videos
Autoantibodies against cell adhesion molecules in pemphigus
1Dermatology Division, Tokyo Electric Power Hospital, Japan.
The Journal of Dermatology
|November 1, 1994
Summary
Pemphigus autoantigens are desmogleins. Molecular engineering revealed pathogenic epitopes on pemphigus vulgaris antigen (PVA), and a recombinant protein (PVIg) absorbed autoantibodies, preventing blister formation.
Area of Science:
- Molecular biology
- Immunology
- Dermatology
Background:
- Pemphigus vulgaris (PV) and pemphigus foliaceus are autoimmune blistering diseases.
- Autoantigens in these diseases belong to the desmoglein subfamily of cadherins.
Purpose of the Study:
- To understand the pathophysiology of pemphigus using molecular engineering.
- To identify pathogenic epitopes on pemphigus vulgaris antigen (PVA).
- To develop a therapeutic agent targeting pathogenic autoantibodies.
Main Methods:
- cDNA cloning of pemphigus autoantigens.
- Molecular engineering of chimeric molecules and bacterial fusion proteins.
- Baculovirus expression of secreted recombinant PVA (PVIg).
- Immunoabsorption assays and neonatal mouse models.
Main Results:
- The extracellular domain of PVA mediates homophilic cell adhesion.
- Major immunogenic domains of PVA are EC1, EC2, and EC4.
- A pathogenic epitope is located on the amino-terminal region of PVA.
- PVIg absorbed pathogenic autoantibodies and prevented blister formation in mice.
Conclusions:
- The extracellular domain of PVA is crucial for cell adhesion and contains pathogenic epitopes.
- Recombinant PVIg shows therapeutic potential by neutralizing autoantibodies in pemphigus.